These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8894943)

  • 21. Effects of flecainide on termination of atrial flutter by rapid atrial pacing.
    Heldal M; Orning OM
    Eur Heart J; 1993 Mar; 14(3):421-4. PubMed ID: 8458365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of atrial flutter after the Fontan procedure.
    Balaji S; Johnson TB; Sade RM; Case CL; Gillette PC
    J Am Coll Cardiol; 1994 Apr; 23(5):1209-15. PubMed ID: 8144791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial flutter.
    Campbell RW
    Eur Heart J; 1998 May; 19 Suppl E():E37-40, E60-3. PubMed ID: 9717023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated neonatal atrial flutter: clinical features, prognosis and therapy.
    Drago F; Mazza A; Garibaldi S; Mafrici A; Santilli A; Ragonese P
    G Ital Cardiol; 1998 Apr; 28(4):365-8. PubMed ID: 9616850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M; Orning OM
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2309-10. PubMed ID: 2505404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of antiarrhythmic drug action on termination of atrial flutter.
    Tai CT; Chen SA
    Pacing Clin Electrophysiol; 2001 May; 24(5):824-34. PubMed ID: 11388102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial flutter with 1:1 conduction in a 70-year-old man with hyperthyroidism.
    Turfan M; Turkoglu S; Ozdemir M; Abaci A
    Cardiol J; 2008; 15(6):555-7. PubMed ID: 19039761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    Manz M; Lüderitz B
    Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The potentials for curing atrial flutter by the combined use of transesophageal electrical stimulation and anti-arrhythmia preparations].
    Grosu AA; Shevchenko NM
    Ter Arkh; 1990; 62(1):36-9. PubMed ID: 2333614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proarrhythmic Antiarrhythmic.
    Pollet M; Saeed M
    Tex Heart Inst J; 2016 Dec; 43(6):507-508. PubMed ID: 28100969
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms and medical management of patients with atrial flutter.
    Waldo AL; Mackall JA; Biblo LA
    Cardiol Clin; 1997 Nov; 15(4):661-76. PubMed ID: 9403167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
    Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
    Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the novel calcium antagonist R(+)-semotiadil in limiting the ventricular rate during atrial flutter in isolated guinea pig hearts.
    Schwarzl I; Stark U; Brodmann M; Haiden U; Tritthart HA; Stark G
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):309-14. PubMed ID: 10672866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic suppression of atrial flutter induced by atrial stimulation.
    Davis WR; Schaal SF
    Am Heart J; 1992 Mar; 123(3):681-6. PubMed ID: 1539519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.